Skip to main content
Top
Published in: Allergy, Asthma & Clinical Immunology 3/2010

Open Access 01-11-2010 | Poster presentation

CD103 in the development of experimental asthma

Authors: Marie-Renee Blanchet, Matthew Gold, Jami Bennett, Kelly McNagny

Published in: Allergy, Asthma & Clinical Immunology | Special Issue 3/2010

Login to get access

Excerpt

CD103 (Alpha-E Beta-7 integrin) is expressed on various cell types involved in the development of asthma, including dendritic cells (DCs) and CD4 and CD8 T regulatory cells. This integrin binds E-cadherin on epithelial cells and plays a role in regulating the migration and proliferation of cells. Also, CD103+ dendritic cells have been reported to direct the development of naïve T cells into T regulatory cells. However, little is known about the exact role of CD103 in the development of asthma. The objective of this project is to investigate the role of this integrin in asthma pathogenesis, in the hope of finding new molecular targets for the treatment of asthma. …
Metadata
Title
CD103 in the development of experimental asthma
Authors
Marie-Renee Blanchet
Matthew Gold
Jami Bennett
Kelly McNagny
Publication date
01-11-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1710-1492-6-S3-P11

Other articles of this Special Issue 3/2010

Allergy, Asthma & Clinical Immunology 3/2010 Go to the issue